We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Survival trends for left and right sided colon cancer using population‐based SEER database: A forty‐five‐year analysis from 1975 to 2019.
- Authors
Ulanja, Mark B.; Asafo‐Agyei, Kwabena Oppong; Neelam, Vijay; Beutler, Bryce D.; Antwi‐Amoabeng, Daniel; Governor, Samuel B.; Rahman, Ganiyu A.; Djankpa, Francis T.; Ulanja, Reginald N.; Nteim, Grace B.; Mabrouk, Tarig; Amankwah, Millicent; Alese, Olatunji B.
- Abstract
Background: Survival differences between left‐sided colon cancer (LSCC) and right‐sided colon cancer (RSCC) has been previously reported with mixed results, with various study periods not accounting for other causes of mortality. Purpose: We sought to assess the trends in colon cancer cause‐ specific survival (CSS) and overall survival (OS) based on sidedness. Method: Fine‐Gray competing risk and Cox models were used to analyze Surveillance, Epidemiology, and End Results (SEER) population‐based cohort from 1975 to 2019. Various interval periods were identified based on the timeline of clinical adoption of modern chemotherapy (1975–1989, interval period A; 1990–2004, B; and 2005–2019, C). Results: Of the 227,637 patients, 50.1% were female and 46.2% were RSCC. RSCC was more common for African Americans (51.5%), older patients (age ≥65; 51.4%), females (50.4%), while LSCC was more common among Whites (53.1%; p < 0.001), younger patients (age 18–49, 64.6%; 50–64, 62.3%; p < 0.001), males (58.1%; p < 0.001). The Median CSS for LSCC and RCC were 19.3 and 16.7 years respectively for interval period A (1975–1989). Median CSS for interval periods B and C were not reached (more than half of the cohort was still living at the end of the follow‐up period). Adjusted CSS was superior for LSCC versus RSCC for the most recent interval period C (HR 0.89; 0.86–0.92; p < 0.001). LSCC consistently showed superior OS for all study periods. Stage stratification showed worse CSS for localized and regional LSCC in the earlier study periods, but the risk attenuated over time. However, left sided distant disease had superior CSS per stage for all interval periods. OS was better for LSCC irrespective of stage, with gradual improvement over time. Conclusion: LSCC was associated with superior survival compared to right sided tumors. With the adoption of modern chemotherapy regimens, prognosis between LSCC and RSCC became more divergent in favor of LSCC. Colon cancer clinical trials should strongly consider tumor sidedness as an enrollment factor.
- Subjects
COLON cancer; DATABASES; OLDER patients; OVERALL survival; COMPETING risks; LEFT ventricular hypertrophy
- Publication
Cancer Medicine, 2024, Vol 13, Issue 8, p1
- ISSN
2045-7634
- Publication type
Article
- DOI
10.1002/cam4.7145